Related Experiment Video
Updated: Jan 31, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Defining the aetiology of paediatric community-acquired pneumonia: an unsolved problem
Susanna Esposito1, Nicola Principi2
1a Pediatric Clinic, Department of Surgical and Biomedical Sciences , Università degli Studi di Perugia , Perugia , Italy.
Insights
Pediatric community-acquired pneumonia (CAP) is a global health issue. Current treatment relies on pathogen probability, but new tests could reduce unnecessary antibiotic use and combat resistance.
Area of Science:
- Pediatric infectious diseases
- Respiratory medicine
- Clinical microbiology
Background:
- Pediatric community-acquired pneumonia (CAP) is a significant worldwide health concern.
- Current etiological knowledge of CAP is limited, leading to probability-based treatment decisions.
- Over-reliance on antibiotics for pediatric CAP contributes to resistance and adverse events.
Purpose of the Study:
- To review current knowledge on the etiology of pediatric CAP.
- To discuss limitations in etiological studies for pediatric CAP.
- To explore diagnostic tests for differentiating viral from bacterial infections in pediatric CAP.
Main Methods:
- This is a narrative review.
- The review synthesizes existing literature on pediatric CAP etiology.
- It examines diagnostic approaches and their limitations.
Main Results:
- Therapeutic decisions for pediatric CAP are based on the likelihood of bacterial infection and common pathogens.
- Antibiotic overuse is prevalent due to fear of untreated bacterial CAP, despite being unnecessary in many cases.
- Biomarker-based point-of-care tests could significantly decrease antibiotic prescriptions.
Conclusions:
- Accurate differentiation of viral versus bacterial CAP is crucial for appropriate treatment.
- Reducing unnecessary antibiotic use in pediatric CAP is essential to mitigate resistance and adverse effects.
- Development and implementation of point-of-care diagnostic tests are key to improving pediatric CAP management.
Introduction:
Pediatric community-acquired pneumonia (CAP) remains a significant health problem worldwide. Although knowledge in the etiology of CAP is not satisfactory, in most cases, therapy is decided following probability-based criteria that are derived from studies that report the frequency of detection of pathogens in children with CAP. Areas covered: This narrative review discusses the present knowledge on pediatric CAP etiology, the limits of the aetiological studies and the tests for differentiation of viral from bacterial infections. Expert commentary: The type of therapeutic approach in pediatric CAP is chosen considering the risk of bacterial etiology and the pathogens most frequently detected in the different pediatric ages. Fear of the potential negative course of unrecognized and untreated bacterial CAP is the main reason for the large use of antibiotics. Unfortunately, the antibiotic prescription is unnecessary in most of the cases as it can favor the emergence of resistant strains and can increase the number of drug-related adverse events. However, it is likely that a significant reduction of antibiotic prescriptions will occur when point-of-care tests with biomarkers for differentiation viral from bacterial infections become available.
More Related Videos
Related Concept Videos
What are Populations and Communities?
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Defining Psychology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Defining Social Psychology

